Munir Ahmad, MD
Radiation Oncology · Belpre, OHNPI 1427113083
Payments from drug & device makers
Across 39 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$193
- Medtronic$105
- Sanofi$104
- Lilly USA, LLC$35
- AstraZeneca$33
- Novartis$29
- plus $189 from 11 others
What the payments were for
- Food & beverage$67598%
- Education$122%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 11 | $193 |
| Medtronic(2 entities) | 3 | $105 |
| Sanofi | 7 | $104 |
| Lilly USA, LLC | 3 | $35 |
| AstraZeneca | 2 | $33 |
| Novartis | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Myovant Sciences Inc. | 1 | $23 |
| Bristol Myers Squibb | 1 | $21 |
| Eisai Inc. | 1 | $18 |
| Progenics Pharmaceuticals, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Incyte Corporation | 1 | $15 |
| GSK | 1 | $15 |
| Seagen Inc. | 1 | $14 |
| Sobi, Inc | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$687 in reported general payments places this provider in the 55th percentile of 255 radiation oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SsdSilver Sulfadiazine | 15 | $320 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Belpre
- Shlomo KoyfmanCleveland$2.4M
- Arnab ChakravartiColumbus$1.4M
- Angela Yuanyuan JiaCleveland$1M
- Daniel SprattCleveland$834K
- Steven KurtzmanGarfield Heights$833K
- Jeremy BrownsteinColumbus$522K
- Sasha BeyerColumbus$504K
- John BrenemanCincinnati$503K
- Joshua PalmerColumbus$453K
- Kyle WangCincinnati$412K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.